MEDROXYPROGESTERONE acetate oral

Select language:
Permalink

Last updated: October 2021

 

Prescription under medical supervision

Therapeutic action

  • Progestogen

Indications

  • Abnormal uterine bleeding (especially functional uterine bleeding unrelated to pregnancy)

Forms and strengths

  • 10 mg tablet

Dosage and duration

Persistent abnormal uterine bleeding despite tranexamic acid therapy or heavy bleeding when tranexamic acid is contra-indicated

  • Adolescent and adult: 20 mg 3 times daily for 7 days
     

Long-term treatment of functional uterine bleeding 

  • Adult: 10 mg once daily (up to 30 mg once daily if necessary). Continue treatment according to clinical response.

Contra-indications, adverse effects, precautions

  • Do not administer to patients with breast cancer, severe hypertension (≥ 160/100), active thromboembolic disorders, uncontrolled or complicated diabetes, severe or recent hepatic disease.
  • May cause: menstrual irregularities, amenorrhoea, menometrorrhagia, breast tenderness, headache, weight gain, acne, mood change, abdominal pain, gastrointestinal disturbances.
  • Pregnancy: CONTRA-INDICATED
  • Breast-feeding: no contra-indication

Remarks

  • Unlike injectable medroxyprogesterone, the oral form has no contraceptive effect.

Storage 

 
– Below 25 °C